Next Article in Journal
The Gilded Clot: Review of Metal-Modulated Platelet Activation, Coagulation, and Fibrinolysis
Next Article in Special Issue
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
Previous Article in Journal
Synthesis and Structural Studies of New Selenium Derivatives Based on Covalent Functionalization of MWCNTs
Previous Article in Special Issue
Thyroid Hormone Receptor β Knockdown Reduces Suppression of Progestins by Activating the mTOR Pathway in Endometrial Cancer Cells
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 24
Issue 4
10.3390/ijms24043296
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility

by
Ishfaq Ahmad Sheikh
1,2,*,
Mohd Amin Beg
1,
Taha Abo-Almagd Abdel-Meguid Hamoda
3,
Hammam Mahmoud Siraj Mandourah
3 and
Erdogan Memili
4
1
King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Department of Urology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4
College of Agriculture and Human Sciences, Prairie View A&M University, Prairie View, TX 77446, USA
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(4), 3296; https://doi.org/10.3390/ijms24043296
Submission received: 27 December 2022 / Revised: 27 January 2023 / Accepted: 4 February 2023 / Published: 7 February 2023
(This article belongs to the Special Issue Thyroid Hormone Derivatives and Thyroid Hormone Receptors)
Browse Figures
Versions Notes

Abstract

:
Polybrominated diphenyl ethers (PBDEs) are a common class of anthropogenic organobromine chemicals with fire-retardant properties and are extensively used in consumer products, such as electrical and electronic equipment, furniture, textiles, and foams. Due to their extensive use, PBDEs have wide eco-chemical dissemination and tend to bioaccumulate in wildlife and humans with many potential adverse health effects in humans, such as neurodevelopmental deficits, cancer, thyroid hormone disruption, dysfunction of reproductive system, and infertility. Many PBDEs have been listed as chemicals of international concern under the Stockholm Convention on Persistent Organic Pollutants. In this study, the aim was to investigate the structural interactions of PBDEs against thyroid hormone receptor (TRα) with potential implications in reproductive function. Structural binding of four PBDEs, i.e., BDE-28, BDE-100, BDE-153 and BDE-154 was investigated against the ligand binding pocket of TRα using Schrodinger’s induced fit docking, followed by molecular interaction analysis and the binding energy estimation. The results indicated the stable and tight binding of all four PDBE ligands and similarity in the binding interaction pattern to that of TRα native ligand, triiodothyronine (T3). The estimated binding energy value for BDE-153 was the highest among four PBDEs and was more than that of T3. This was followed by BDE-154, which is approximately the same as that of TRα native ligand, T3. Furthermore, the value estimated for BDE-28 was the lowest; however, the binding energy value for BDE-100 was more than BDE-28 and close to that of TRα native ligand, T3. In conclusion, the results of our study suggested the thyroid signaling disruption potential of indicated ligands according to their binding energy order, which can possibly lead to disruption of reproductive function and infertility.

1. Introduction

Endocrine-disrupting chemicals (EDCs) are exogenous compounds that interfere with normal functions of the endocrine system, resulting in various endocrine disorders, such as metabolic diseases, neuroendocrine dysfunctions, cancers, reproductive abnormalities, etc. [1,2,3]. The adverse effects can occur through EDC actions at multiple stages in an endocrine system, and hence various mechanisms of action have been reported. These include stimulatory or inhibitory binding to a hormone receptor, inhibition or stimulation of endogenous hormone production, inhibition or stimulation of hormone receptor expression or epigenetic effects [4,5]. Nevertheless, all the indicated mechanisms are expected to disrupt the normal functioning of an endocrine system [4,5]. According to a Health and Environment Alliance (HEAL) report, the proportion of diseases that could be attributed to EDCs is assumed to be 2–5% [6]. According to an estimate for European Union, more than 20% of EDC causation was attributed to diseases, such as IQ loss and associated intellectual problems, autism, attention-deficit hyperactivity disorder, childhood obesity, adult obesity, adult diabetes, cryptorchidism, male infertility, and mortality associated with reduced testosterone, resulting in an economic burden of 209 billion US dollars [7]. Hypothalamic-pituitary-thyroid (HPT) axis is one of the important potential targets of endocrine disruption. The HPT axis is a critical endocrine signaling system in the body responsible for regulating metabolic, growth, and developmental processes [8]. The main end-effector hormones of the HPT axis are thyroxine (T4) and biologically active triiodothyronine (T3). The thyroid hormones are critical for the function of almost all the cells and organ systems in the body, including the heart, nervous system, bone, gastrointestinal tract, musculoskeletal system, reproductive system, etc. [9,10]. For our purpose, the role of thyroid hormones in human reproduction and fertility will be the focus of the discussion to have a better understanding of the mechanism. In this regard, thyroid hormones play a significant role in human reproductive physiology and fertility [9,11,12,13,14]. Briefly, in men, thyroid hormones through their cognate receptor have critical effects on the development of the testis, regulation of spermatogenesis and steroidogenesis, secretion of gonadal (testosterone) and pituitary (FSH and LH) reproductive hormones, and fertility. In addition to affecting Leydig and Sertoli cells, thyroid hormones also have effects on germ cells [15]. In addition, thyroid hormones have effects on epididymis and other accessory sex organs and are important for normal morphology and quality of spermatozoa and their transport in the male reproductive system. Thyroid hormones are also important for maintaining a healthy male libido and for ensuring that the body has enough energy to complete the process of reproduction. Thyroid hormone problems during gestational and neonatal periods have been reported to have a profound adverse effect later on spermatogenesis and male reproductive function [12]. Men with impaired thyroid function have a lower sperm count, lower levels of testosterone, and higher incidences (59% in thyroid dysfunction vs. 30% control) of erectile and ejaculatory dysfunction [11,12,16]. In women, thyroid hormones are vital to the proper functioning of the reproductive system as a primary regulator of metabolism and development of ovarian, uterine, and placental tissues [9,11,17]. Women who have thyroid dysfunction experience several physiological and behavioral changes, including reproductive disorders leading to irregular periods, ovulation problems, fertility issues, miscarriage, premature birth, and low neonatal birth weight [17]. Hence, regarding EDCs, any homeostatic imbalance in thyroid function due to EDCs has the potential to result in reproductive problems and infertility in men and women as indicated above. Polybrominated diphenyl ethers (PBDEs) are a group of most used brominated flame retardants with extensive application in various consumer products to prevent the spread of fire [18]. However, epidemiological studies have suggested that PBDEs act as EDCs, can interfere with several biological processes, such as neurodevelopmental function and cognitive development, thyroid hormone action, and reproductive development and function, and may even be associated with cancer development, etc. [19,20,21,22,23,24,25]. In total, 209 possible different congeners of PBDEs have been reported based on the position and number of the bromine atoms attached to phenyl ring [26,27]. Nevertheless, PBDEs are used as additives and are non-covalently linked to the polymer matrix. Therefore, they can easily leach out from these products into the environment and are hence ubiquitously present in the air, animals, food, and indoor and outdoor environment [27]. They enter the human body through various routes; however, the main routes of PBDEs exposure in humans are contaminated food ingestion followed by contaminated dust inhalation [28,29,30,31,32,33,34,35,36]. PBDEs were listed as Persistent Organic Pollutants (POPs) by the Stockholm Convention in 2009 and 2017 [26]. Therefore, restrictions have been imposed on their use in Europe and the United States, resulting in their phase-out from the market. First, the penta-BDEs and octa-BDEs commercial mixtures were banned from North America and European Union in 2004. Later on, the restrictions on the deca-BDE mixture were placed in 2019; the deca-BDE mixture is only allowed for the production of aeronautics and automobile spare parts [37,38,39]. Nevertheless, PBDEs continue to be a serious challenge in many countries because of their constant release from PBDE-containing products [40,41]. It is estimated that PBDEs will continue to discharge into the environment from in-use stock products and waste until 2050 [42]. Furthermore, many countries have not restricted the use of PBDEs and are still extensively manufacturing and using PBDEs for commercial products [43,44]. In addition to the manufacturing and use, the recycling of PBDEs containing products [45] and the environmental stability of PBDEs [46] also contribute to their ubiquitous environmental presence. Numerous studies have reported the association of PBDE exposure with adverse health outcomes. The economic burden associated with PBDE exposure and associated health outcomes is significant. According to the latest reports, the economic cost of EDC exposure in Canada was CAD 24.6 billion, and the main driver for costs was PBDE-associated health abnormalities amounting to CAD 11.5 billion [47]. Similarly, this cost was USD 340 billion in the United States, and again the major portion of the cost amount was related to PBDE exposure amounting to USD 266 billion. Likewise, in Europe, the economic cost was estimated to amount to USD 217 billion, and USD 12.6 billion was associated with PBDE exposure [48].
PBDEs share their chemical structural resemblance with thyroid hormones, and hence have the potential to interfere with thyroid hormone action. The possible mechanisms include competitive binding with thyroid hormone receptors (TRα) and thyroid hormone transport proteins [49,50,51,52] and an increase in metabolism and clearance of T4 [53]. Numerous studies have reported that PBDEs interfere with T4 transport causing thyroid dysfunction [50,54,55]. In addition, PBDE exposure was associated with adverse effects on penile length, sex hormone binding globulin, testosterone concentrations [56], and shorter anogenital distance [57]. In addition, human studies have reported an inverse association between sperm mobility and PBDE exposure [58]. Furthermore, a detailed review of the literature on the mechanisms of PBDE-induced male reproductive toxicity is also presented [59]. PBDE exposure in adult male rats has shown abnormal reproductive organ weight and sperm count [60,61].
Some of the ubiquitously detected PBDEs are BDE-28, BDE-100, BDE-153, and BDE-154. Perusal of the literature indicated that in general very limited studies are available on the structural binding aspects of PBDEs with TRα. In addition, in silico structural binding characterization of TRα with BDE-28, BDE-100, BDE-153, and BDE-154 has not been reported to the best of our knowledge. Furthermore, the comparative analysis of structural binding parameters and the potential thyroid dysfunction activity as discussed above indicates all four PBDE ligands have not been reported. Therefore, the present study was performed to investigate the structural binding characterization of PBDEs: BDE-28, BDE-100, BDE-153, and BDE-154 against the ligand binding pocket of TRα. The induced fit docking approach was used to perform this docking simulation study. The overall aim of this study was to investigate the potential thyroid dysfunction activity of aforementioned PBDEs with implications for reproductive function and infertility.

2. Results

The best-chosen poses for all the indicated ligands, BDE-28, BDE-100, BDE-153, BDE-154, and the TRα native ligand, T3, were carried forward for further analysis. The final chosen poses for all the ligands exhibiting molecular interaction of amino acid residues with respective ligands are presented (Figure 1). The BDE-28 displayed interactions with 22 amino acid residues of TRα (Figure 1a). Further, 21 amino acid residues of TRα were observed exhibiting interactions with BDE-100 (Figure 1b). However, 19 amino acid residues of TRα displayed interactions with BDE-153 (Figure 1c), and for BDE-154, the number of amino residues involved in interactions with TRα was 18 (Figure 1d).

2.1. Induced Fit Docking of BDE-28 with Thyroxine Receptor-α

The TRα/BDE-28 docking complex displayed several amino acid residue interactions of TRα with ligand BDE-28 in the binding pocket. Overall, 22 TRα amino acid residues displayed various molecular interactions, such as hydrophobic, hydrogen bonding, van der Waals interactions, etc., with the ligand BDE-28. The amino acid residues involved in various interactions were Thr-178, Asn-179, Ala-180, Phe-218, Ile-221, Il2-222, Ala-225, Arg-228, Val-229, Met-256, Met-259, Ser-260, Arg-262, Ala-263, Arg-266, Thr-275, Leu-276, Ser-277, Gly-278, Leu-287, Leu-292, and Ile-299 (Figure 1a).
Similarly, the molecular interaction of TRα native ligand, T3, with TRα amino acid residues is also presented (Figure 2). Altogether, 23 TRα amino acid residues displayed various molecular interactions with ligand T3, i.e., Phe-215, Phe-218, Thr-219, Ile-221, Il2-222, Ala-225, Arg-228, Met-256, Met-259, Ser-260, Arg-262, Ala-263, Arg-266, Thr-275, Leu-276, Ser-277, Gly-278, Leu-287, Gly-290, Leu-292, Ile-199, His-381, and Phe-401. In addition, three amino acid residues Arg-228, Arg-266 and His-381 each exhibited one hydrogen bonding interaction with ligand native ligand, T3. In addition, Arg-228 also displayed one salt bridge interaction with the native ligand (Figure 2).
The other parameters such as IFD, Dock score, and Glide score, essential for structural binding analysis and characterization of BDE-28 and TRα native ligand, T3, are presented (Table 1). In addition, another important parameter essential for analysis is binding energy, the estimated binding energy values are also presented (Table 1). However, the estimated binding energy value for TRα native ligand, T3, is more than that of BDE-28. Furthermore, the commonality of the TRα interacting amino acid residues between the TRα-T3 and TRα-BDE28 docking complexes was approximately 82%. However, four more residues i.e., Thr-178, Asn-179, Ala-180, and Val-229, were also observed interacting with TRα/BDE-28 but were absent in the native ligand (TRα-T3) complex.

2.2. Induced Fit Docking of BDE-100 with Thyroxine Receptor-α

The docking display pose of BDE-100 exhibited 21 amino acid residues engaged in various molecular interactions with TRα (Figure 1b). Furthermore, the comparison between the docking poses of the native ligand, T3, and BDE-100 revealed approximately 86% overlap in amino acid interactions. However, several other molecular interactions were also observed in the TRα-BDE100 complex due to additional amino acid residues i.e., Ile-226, Val-229, and Met-280 (Figure 1b). Furthermore, one pi-cation interaction was also displayed by Arg-228.

2.3. Induced Fit Docking of BDE-153 Ligand with Thyroxine Recepotor-α

The docking display pose of BDE-153 exhibited 19 amino acid residues engaged in various molecular interactions with TRα (Figure 1c). Furthermore, the comparison between the docking poses of the native ligand, T3, and BDE-153 revealed approximately 74% overlap in amino acid interactions. However, several other molecular interactions were also observed in BDE-153/TRα complex due to additional amino acid residues i.e., Leu-274, Val-282, Val-295, Ser-296, and Phe-300 (Figure 1c).

2.4. Induced Fit Docking of BDE-154 Ligand with Thyroxine Receptor-α

The docking display pose of BDE-154 exhibited 18 amino acid residues engaged in various molecular interactions with TRα (Figure 1d). Furthermore, the comparison between the docking poses of the native ligand, T3, and BDE-154 revealed approximately 94% overlap in amino acid interactions. However, one more molecular interaction was also observed in TRα/BDE-154 complex due to additional amino acid residue i.e., Phe-405 (Figure 1d).

3. Discussion

Briefly, the overall results of the IFD experiment suggested the successful and stable placement of all the indicated PBDE flame retardant ligands in the TRα ligand binding pocket. Furthermore, the IFD results also revealed that the structural binding parameters such as IFD score, Docking score, and Glide score estimated for all four ligands were similar to the values estimated for TRα native ligand, T3. In addition, the comparative analysis of the molecular interactions displayed by TRα amino acid residues with all the indicated four PBDEs ligands also showed similarity with the molecular interactions displayed with the TRα native ligand, T3. Furthermore, BDE-153 showed the highest estimated binding energy value among all the ligands, which was even higher than the value calculated for TRα native ligand, T3. This was followed by BDE-154, with an estimated binding energy value approximately similar to that of the TRα native ligand, T3. On contrary, the binding energy value calculated for BDE-28 was the lowest among all the indicated ligands. However, the binding energy value calculated for BDE-100 was also lower but close to the value estimated for TRα native ligand, T3. The overall similarity in structural binding characterization parameters and the docking results between the TRα native ligand, T3, and all four indicated PBDE ligands suggested the resemblance in their binding pattern and position. Therefore, the results predict a potential interference in thyroid hormone signaling by these ligands. The thyroid disruption could further possibly lead to abnormal reproductive function and infertility. Earlier studies have indicated that disruptive thyroid hormone signaling subsequently affects normal reproductive functions such as changes in sex hormone levels, semen quality, spermatogenesis, and erectile abnormalities [12,62]. The potential adverse impact for BDE-153 and BDE-154 seems to be more than for BDE-28 and BDE-100.
In general, very limited studies are available on the structural binding aspects of PBDEs with TRα, and in particular, with the four indicated PBDEs ligands: BDE-28, BDE-100, BDE-153, and BDE-154. However, several in silico studies have reported the potential endocrine-disrupting activity of various PBDE congeners or their structural analogues with other different receptors or transport proteins. For example, Li et al. reported the docking studies of PBDE structural analogues (hydroxylated PBDEs) with TR [63]. Similarly, in our previous study, we reported that BDE-153 structurally interacts with thyroxine binding globulin (TBG) [52]. In another study, we reported the binding of BDE-47, BDE-99, and their structural analogues with TBG [51]. In addition, in vitro studies also indicated PBDEs and their structural analogues compete in binding with TRs and disrupt the thyroid hormone function [63,64].
Several epidemiological studies in humans also suggested impaired thyroid hormone activity due to PBDE exposure. The impaired thyroid hormone activity is indicated by altered T3 and T4 levels [65]. In this regard, the association between maternal and cord sera thyroid hormones and PBDEs was observed [19,21,22,23,24,66,67,68,69,70]. Likewise, the PBDEs showed an association with both higher and lower levels of T3 in pregnant women [22,23]. Several studies have reported an inverse association between the total T3 (TT3) and BDE-153 in pregnant women during the first trimester [21,71]. Another study in human newborns indicated a negative association for prenatal PBDE exposure with total T4 (TT4) and free T4 (FT4) levels in cord blood [72]. A study performed on 260 Canadian pregnant women reported an increase in FT4 concentrations with BDE-47 exposure during the first trimester; however, TT4 showed an inverse association [24]. A study indicated a 4–8% increase in maternal total and free T3 and T4 levels with 10-fold increases in BDE-28 and -47 [73]. Another study reported higher levels of maternal TT4 with a 10-fold increase in BDE-47 concentration [22]. In addition, the hyperthyroid effect was also observed in the human non-pregnant cohort [20,74,75]. A study on women samples from the United States suggested an association between PBDE exposure and thyroid diseases. Furthermore, the observed effects were greater in post-menopause women suggesting that altered estrogen levels in menopause may enhance thyroid signaling disruption by PBDEs [27]. In addition, studies conducted on men have also shown positive associations between PBDE exposure and TT4 and FT4 levels [20,75].
Similarly, laboratory animal studies have also reported altered thyroid hormone levels resulting from PBDE exposure [76]. In this regard, altered T4 levels have been reported on PBDE exposure in rodents, felines, and birds [65,77,78]. However, the majority of the animal studies on rodents indicated reduced serum T4 levels on PBDE exposure causing hypothyroidism [49,53]. The studies on rats reported that PBDEs bind with TBG [79], and an inverse association was observed between PBDE exposure and thyroid hormone levels [80]. Likewise, decreased T4 levels were reported in rat offspring subjected to PBDE exposure during the gestational period [81]. A study reported a significant decrease in T4 levels in pre and postnatally PBDEs exposed rodents [54,82]. A study on zebrafish aimed to understand the transgenerational risks of BDE-209 exposure reported decreased T4 levels and downregulation in the thyroid hormone receptor gene in F1 individuals [83]. Thyroid hormones have a critical role in the human male and female reproductive system including male reproductive tract development, spermatogenesis, and male fertility [84]. Any interference in thyroid function is a potential cause of male reproductive dysfunction and infertility. In regard to the current study, the results show that thyroid signaling disruption potential of PBDEs is a potential indication of subsequent adverse effects on male fertility. This is further reinforced by human studies that have directly shown an association of PBDEs with adverse effects on reproductive function [85]. In this regard, BDE-153 exposure was associated with adverse effects on sperm concentration and testes volume [86]. Similarly, higher serum levels of BDE-154 were associated with adverse effects on testes volume, sex hormone binding globulin, testosterone concentrations, and penile length [56]. Likewise, another study indicated that BDE-100 exposure was associated with abnormal sex hormone concentrations [20]. A study on a Shanghai (China) birth cohort indicated that prenatal exposure to BDE-100, BDE-153, and other PBDEs in boys was associated with shorter anogenital distance [57]. Previous studies on other PBDEs have also associated their prenatal exposure with disturbed reproductive tract development in infants [56]. Two studies have reviewed the available literature on the reproductive toxicity caused by PBDEs in humans and animals [34,87]. In laboratory animal studies, prenatal exposure to PBDEs (BDE-47, BDE-99, and DE-71) in rats and mice was reported to cause changes in the relative weight of the testis and epididymis. The compounds were also reported to affect the production of sperm [88]. In another study, postnatal exposure to BDE-209 in male mice affected sperm motion and motility [89]. In addition, exposure to the penta-BDE mixture [61] or deca-BDE [90] in adult male rats resulted in a decrease in the weight of epididymis and seminal vesicle along with a decrease in serum T4 levels. A study in adult male rats suggested that prenatal BDE-47 exposure at environmentally relevant doses causes dysregulation in histone–protamine exchange during spermatogenesis and can potentially result in an aberrant sperm epigenome [91]. Nevertheless, this study is of significant relevance in assessing the impact of environmental toxicants on reproductive outcomes in couples seeking fertility treatment. This study, however, has several limitations. First, this study is a molecular docking simulation study that in itself has its own limitations. Therefore, studies using in vitro and in vivo model systems are suggested to confirm the results. Secondly, our study is an indirect extrapolation of thyroid disruption effects of PBDEs on reproductive function. Therefore, further direct in silico, in vitro, and in vivo studies are suggested to evaluate the association of PBDEs with reproductive dysfunction. The integrated systems biology approach using various model systems is required to overcome these limitations and gain deeper insights into the effects of PBDE on reproductive dysfunction and fertility.

4. Materials and Methods

The three-dimensional structural coordinates of PBDE flame retardants: BDE-28, BDE-100, BDE-153, and BDE-154, were downloaded from the PubChem compound database (https://pubchem.ncbi.nlm.nih.gov/) on 10 June 2021. The aforementioned ligands were chosen as they are very commonly used PBDEs and are detected in a large section of the population [92]. It was followed by structural binding characterization of these ligands using Schrodinger 2017 suite with Maestro 11.4 as a graphical user interface (Schrodinger, LLC, New York, NY, USA, 2017). The detailed methodology is described in our previous studies [93,94].

4.1. Protein Preparation

The Protein Data Bank (PDB; http://www.rcsb.org/) was searched on 11 June 2021, and three-dimensional structural coordinates solved at 1.87 Å resolution for the crystal complex of ligand T3 with TRα (PDB code: 2H79) were retrieved. The retrieved coordinates were imported to Glide docking software, and the protein crystal complex was subjected to further processing and prepared for docking studies using the protein preparation wizard workflow of Schrodinger Glide (Schrodinger suite 2017-4; Schrodinger, LLC) as described previously [93,94]. Briefly, the missing hydrogen atoms and charges were added, and water molecules were removed from the crystal complex structure. The metal ionization states were corrected, and the bond order to HET groups was also enumerated. In addition, the N-terminal and the C-terminal of the protein were capped with ACE (N-acetyl) and NMA (N-methyl amide), respectively. The amino acid residues of the protein receptor with multiple occupancies or missing atoms were also highlighted during this step. It was followed by hydrogen bond network optimization by means of a systematic, cluster-based approach and energy minimization steps.

4.2. Ligand Preparation

The three-dimensional structural coordinates for commonly used PBDE flame retardants: BDE-28, BDE-100, BDE-153, and BDE-154, were downloaded from the PubChem compound database (https://pubchem.ncbi.nlm.nih.gov/) on 10 June 2021. The PubChem compound identity for all the PBDE ligands is mentioned in Table 1. These ligands were processed and prepared for simulation studies by the LigPrep module of Schrodinger (Schrodinger 2017: LigPrep, Schrodinger, LLC, New York, NY, USA), which is a very efficient module preparing approximately one ligand per second for further computational processes. The Ligprep module corrects the Lewis structure and also the mistakes in the ligand. It produces an accurate three-dimensional structure of the ligand following the minimization step. Furthermore, the structures that fail to meet user-specified criteria are removed using the filter. In addition, various possible ring conformations, stereoisomers, tautomeric and ionization states are also generated from the given input ligand structure. The two-dimensional structures of BDE-28, BDE-100, BDE-153, and BDE-154 are presented in Figure 3.

4.3. Induced Fit Docking

The Schrodinger’s Induced Fit Docking (IFD) module was employed to perform the docking of TRα native ligand, T3, and commonly used PBDE flame retardants: BDE-28, BDE-100, BDE-153, and BDE-154 in the TRα ligand binding pocket as described in detail previously [93,94]. Briefly, we first generated a grid at TRα native ligand, T3, binding site. It was followed by constrained minimization of TRα using the protein preparation step. The IFD induces flexibility in both the ligand as well as ligand binding pocket of the protein receptor and does not adopt a rigid docking approach. Initial Glide docking was performed using a softened potential and optional side chain removal for all the ligands, and by default, twenty docking poses were retained. The side chains in amino acids were predicted followed by energy minimization for receptor as well as ligand in each pose. It was followed by Glide re-docking and IFD score estimation. Likewise, an extended sampling protocol was also performed. All four indicated ligands exhibited successful docking in the TRα ligand binding pocket and were placed stably in the TRα ligand binding pocket following IFD, indicating their stable binding. The IFD approach generated several docking poses for each ligand; however, only the best poses were chosen and carried forward for structural characterization. Likewise, the IFD was also performed on TRα native ligand, T3.

4.4. Binding Affinity Calculations

The binding affinity of BDE-28, BDE-100, BDE-153, and BDE-154 for TRα ligand binding pocket was estimated using the MMGB-SA function in the Prime module of Schrodinger 2017 as described previously [93,94]. The estimated binding energy (ΔGBind) values indicate how strongly ligands are bound in the ligand binding pocket. The following equation is used to estimate the binding free energy (Prime MMGBSA DG bind):
ΔGbind = Ecomplex(minimized) − [Eligand(minimized) + Ereceptor(minimized)].
where ΔGBind is binding free energy, and Ecomplex (minimized, Eligand(minimized), and Ereceptor(minimized) are minimized energies of receptor-ligand complex, ligand and receptor respectively.

5. Conclusions

In conclusion, the results of this study suggested that among all the indicated four ligands, BDE-153 and BDE-154 have the higher potential than BDE-100 to interfere with thyroid hormone signaling and impair thyroid function with subsequent adverse implication for reproductive function and fertility. The results also suggested the least thyroid signaling disrupting potential for BDE-28. However, further studies are warranted to enhance the understanding of the role of these PBDE flame retardants in impaired thyroid and reproductive function and associated adverse health effects.

Author Contributions

Conceptualization, I.A.S.; methodology, I.A.S.; software, I.A.S.; validation, I.A.S.; formal analysis, I.A.S.; data analysis I.A.S.; writing—original draft preparation, I.A.S.; writing—review and editing, M.A.B., T.A.-A.A.-M.H., H.M.S.M. and E.M.; supervision, I.A.S.; project administration, I.A.S.; funding acquisition, I.A.S. All authors have read and agreed to the published version of the manuscript.

Funding

Ishfaq Ahmad Sheikh received funding for this study from Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia through the project number (IFPRC-041-141-2020).

Institutional Review Board Statement

Not applicable as no human patients or animals were involved in this study.

Informed Consent Statement

Not applicable as no human patients were involved in this study.

Data Availability Statement

Not applicable. All data is contained within the article.

Acknowledgments

The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research work through the project number (IFPRC-041-141-2020) and King Abdulaziz University, DSR, Jeddah, Saudi Arabia.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Patisaul, H.B. Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid. Adv. Pharmacol. 2021, 92, 101–150. [Google Scholar] [PubMed]
  2. Guarnotta, V.; Amodei, R.; Frasca, F.; Aversa, A.; Giordano, C. Impact of Chemical Endocrine Disruptors and Hormone Modulators on the Endocrine System. Int. J. Mol. Sci. 2022, 23, 5710. [Google Scholar] [CrossRef] [PubMed]
  3. Kurşunoğlu, N.E.; Yurekli, B.P.S. Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence. World J. Clin. Cases 2022, 10, 11226–11239. [Google Scholar] [CrossRef] [PubMed]
  4. Schug, T.T.; Janesick, A.; Blumberg, B.; Heindel, J.J. Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 2011, 127, 204–215. [Google Scholar] [CrossRef] [PubMed]
  5. Combarnous, Y.; Nguyen, T.M.D. Comparative Overview of the Mechanisms of Action of Hormones and Endocrine Disruptor Compounds. Toxics 2019, 7, 5. [Google Scholar] [CrossRef] [PubMed]
  6. Health costs in the European Union. How Much Is Related to EDCs? 2014. Available online: https://www.env-health.org/IMG/pdf/heal_policy_statement_en.pdf (accessed on 10 December 2022).
  7. Trasande, L.; Zoeller, R.T.; Hass, U.; Kortenkamp, A.; Grandjean, P.; Myers, J.P.; DiGangi, J.; Bellanger, M.; Hauser, R.; Legler, J.; et al. Estimating Burden and Disease Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union. J. Clin. Endocrinol. Metab. 2015, 100, 1245–1255. [Google Scholar] [CrossRef]
  8. McNabb, F.M.A.; Darras, V.M. Thyroids. Sturkie’s Avian Physiology. Elsevier: Amsterdam, The Netherlands, 2015; pp. 535–547. [Google Scholar]
  9. Brtko, J. Thyroid hormone and thyroid hormone nuclear receptors: History and present state of art. Endocr. Regul. 2021, 55, 103–119. [Google Scholar] [CrossRef]
  10. Shahid, M.A.; Ashraf, M.A.; Sharma, S. Physiology, Thyroid Hormone. [Updated 2022 May 8]. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2022. [Google Scholar]
  11. Krassas, G.E.; Poppe, K.; Glinoer, D. Thyroid function and human reproductive health. Endocr. Rev. 2010, 31, 702–755. [Google Scholar] [CrossRef]
  12. Singh, R.; Hamada, A.J.; Agarwal, A. Thyroid Hormones in Male Reproduction and Fertility. Open Reprod. Sci. J. 2011, 3, 98–104. [Google Scholar]
  13. Jefferys, A.; Vanderpump, M.; Yasmin, E. Thyroid dysfunction and reproductive health. Obstet. Gynaecol. 2015, 17, 39–45. [Google Scholar] [CrossRef]
  14. Zavaleta, M.C.; Ibarra, J.L.P.; Yataco, A.R.; Arroyo, J.C.; Urteaga, L.C.; Roseboom, P.J.; Williams, C.A. Assessment of hormonal status in male infertility. An update. Diabetes Metab. Syndr. 2022, 16, 102447. [Google Scholar] [CrossRef] [PubMed]
  15. Hernandez, A.; Martinez, M.E. Thyroid hormone action in the developing testis: Intergenerational epigenetics. J. Endocrinol. 2020, 244, R33–R46. [Google Scholar] [CrossRef] [PubMed]
  16. Veronelli, A.; Masu, A.; Ranieri, R.; Rognoni, C.; Laneri, M.; Pontiroli, A.E. Prevalence of erectile dysfunction in thyroid disorders: Comparison with control subjects and with obese and diabetic patients. Int. J. Impot. Res. 2006, 18, 111–114. [Google Scholar] [CrossRef]
  17. Silva, J.F.; Ocarino, N.M.; Serakides, R. Thyroid hormones and female reproduction. Biol. Reprod. 2018, 99, 907–921. [Google Scholar] [CrossRef] [PubMed]
  18. Segev, O.; Kushmaro, A.; Brenner, A. Environmental impact of flame retardants (persistence and biodegradability). Int. J. Environ. Res. Public Health 2009, 6, 478–491. [Google Scholar] [CrossRef]
  19. Herbstman, J.B.; Sjodin, A.; Apelberg, B.J.; Witter, F.R.; Halden, R.U.; Patterson, D.G.; Panny, S.R.; Needham, L.L.; Goldman, L.R. Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated diphenyl ether (PBDE) and neonatal thyroid hormone levels. Environ. Health Perspect. 2008, 116, 1376–1382. [Google Scholar] [CrossRef]
  20. Meeker, J.D.; Johnson, P.I.; Camann, D.; Hauser, R. Polybrominated diphenyl ether (PBDE) concentrations in house dust are related to hormone levels in men. Sci. Total Environ. 2009, 407, 3425–3429. [Google Scholar] [CrossRef]
  21. Chevrier, J.; Harley, K.G.; Bradman, A.; Gharbi, M.; Sjodin, A.; Eskenazi, B. Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy. Environ. Health Perspect. 2010, 118, 1444–1449. [Google Scholar] [CrossRef]
  22. Stapleton, H.M.; Eagle, S.; Anthopolos, R.; Wolkin, A.; Miranda, M.L. Associations between polybrominated diphenyl ether (PBDE) flame retardants, phenolic metabolites, and thyroid hormones during pregnancy. Environ. Health Perspect. 2011, 119, 1454–1459. [Google Scholar] [CrossRef]
  23. Zota, A.R.; Park, J.S.; Wang, Y.; Petreas, M.; Zoeller, R.T.; Woodruff, T.J. Polybrominated diphenyl ethers, hydroxylated polybrominated diphenyl ethers, and measures of thyroid function in second trimester pregnant women in california. Environ. Sci. Technol. 2011, 45, 7896–7905. [Google Scholar] [CrossRef]
  24. Abdelouahab, N.; Langlois, M.F.; Lavoie, L.; Corbin, F.; Pasquier, J.C.; Takser, L. Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. Am. J. Epidemiol. 2013, 178, 701–713. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Zoeller, R.T.; Bergman, A.; Becher, G.; Bjerregaard, P.; Bornman, R.; Brandt, I.; Iguchi, T.; Jobling, S.; Kidd, K.A.; Kortenkamp, A.; et al. A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ. Health 2014, 13, 118. [Google Scholar] [CrossRef] [PubMed]
  26. Wu, Z.; He, C.; Han, W.; Song, J.; Li, H.; Zhang, Y.; Jing, X.; Wu, W. Exposure pathways, levels and toxicity of polybrominated diphenyl ethers in humans: A review. Environ. Res. 2020, 187, 109531. [Google Scholar] [CrossRef] [PubMed]
  27. Allen, J.G.; McClean, M.D.; Stapleton, H.M.; Webster, T.F. Linking pbdes in house dust to consumer products using x-ray fluorescence. Environ. Sci. Technol. 2008, 42, 4222–4228. [Google Scholar] [CrossRef] [PubMed]
  28. Allen, J.G.; Gale, S.; Zoeller, R.T.; Spengler, J.D.; Birnbaum, L.; McNeely, E. PBDE Flame Retardants, Thyroid Disease, and Menopausal Status in U.S. Women. Environ. Health 2016, 15, 60. [Google Scholar] [CrossRef] [PubMed]
  29. Johnson-Restrepo, B.; Kannan, K. An assessment of sources and pathways of human exposure to polybrominated diphenyl ethers in the United States. Chemosphere 2009, 76, 542–548. [Google Scholar] [CrossRef]
  30. Frederiksen, M.; Vorkamp, K.; Thomsen, M.; Knudsen, L.E. Human internal and external exposure to PBDEs—A review of levels and sources. Int. J. Hyg. Environ. Health 2009, 212, 109–134. [Google Scholar] [CrossRef]
  31. Bramwell, L.; Glinianaia, S.V.; Rankin, J.; Rose, M.; Fernandes, A.; Harrad, S.; Pless-Mulolli, T. Associations between human exposure to polybrominated diphenyl ether flame retardants via diet and indoor dust, and internal dose: A systematic review. Environ. Int. 2016, 92–93, 680–694. [Google Scholar] [CrossRef]
  32. Shi, Z.; Zhang, L.; Li, J.; Wu, Y. Legacy and emerging brominated flame retardants in China: A review on food and human milk contamination, human dietary exposure and risk assessment. Chemosphere 2018, 198, 522–536. [Google Scholar] [CrossRef]
  33. Tay, J.H.; Sellstr¨om, U.; Papadopoulou, E.; Padilla-S´anchez, J.A.; Haug, L.S.; de Wit, C.A. Serum concentrations of legacy and emerging halogenated flame retardants in a Norwegian cohort: Relationship to external exposure. Environ. Res. 2019, 178, 108731. [Google Scholar] [CrossRef]
  34. Liu, X.; Zhiguo, C.; Gang, Y. Human exposure to emerging halogenated flame retardants. Compr. Anal. Chem. 2020, 88, 215–251. [Google Scholar]
  35. Esplugas, R.; Rovira, J.; Mari, M.; Fern´andez-Arribas, J.; Eljarrat, E.; Domingo, J.L.; Schuhmacher, M. Emerging and legacy flame retardants in indoor air and dust samples of Tarragona Province (Catalonia, Spain). Sci. Total Environ. 2022, 806 Pt 1, 150494. [Google Scholar] [CrossRef] [PubMed]
  36. Marquès, M.; Nadal, M.; Domingo, J.L. Human exposure to polybrominated diphenyl ethers (PBDEs) through the diet: An update of the scientific literature. Food Chem. Toxicol. 2022, 167, 113322. [Google Scholar] [CrossRef] [PubMed]
  37. European Commission. Commission Regulation (EU) 2017/227 of 9 February 2017 Amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as Regards Bis(Pentabromophenyl)Ether. Off. J. Legis. 2017, 35, 6, Published on 09-02-2017. Available online: https://op.europa.eu/en/publication-detail/-/publication/16f3bb9e-ef21-11e6-8a35-01aa75ed71a1/language-en (accessed on 26 December 2022).
  38. Dobslaw, D.; Woiski, C.; Kiel, M.; Kuch, B.; Breuer, J. Plant uptake, translocation and metabolism of PBDEs in plants of food and feed industry: A review. Rev. Environ. Sci. Biotechnol. 2021, 20, 75–142. [Google Scholar] [CrossRef]
  39. Sahu, R.S.; Peng, Y.H.; Ko, C.F.; Chou, T.H.; Catherine, H.N.; Yang, C.Y.; Tso, C.P.; Su, Y.F.; Shih, Y.H. Processes driving the degradation of polybrominated diphenyl ethers in terrestrial environment. Trends Environ. Anal. Chem. 2021, 30, e00126. [Google Scholar] [CrossRef]
  40. Sharkey, M.; Harrad, S.; Abdallah, M.A.E.; Drage, D.S.; Berresheim, H. Phasing-out of legacy brominated flame retardants: The UNEP Stockholm convention and other legislative action worldwide. Environ. Int. 2020, 144, 106041. [Google Scholar] [CrossRef]
  41. Hoang, A.C.; Tran, T.M.; Tu, M.B.; Takahashi, S. Polybrominated diphenyl ethers in indoor and outdoor dust from Southeast Asia: An updated review on contamination status, human exposure, and future perspectives. Environ. Pollut. 2021, 272, 116012. [Google Scholar] [CrossRef]
  42. Abbasi, G.; Li, L.; Breivik, K. Global Historical Stocks and Emissions of PBDEs. Environ. Sci. Technol. 2019, 53, 6330–6340. [Google Scholar] [CrossRef]
  43. Li, J.; Yuan, C.; Wenjing, X. Polybrominated diphenyl ethers in articles: A review of its applications and legislation. Environ. Sci. Pollut. Res. 2017, 24, 4312–4321. [Google Scholar]
  44. Wang, M.; Gao, B.; Tang, D.; Sun, H.; Yin, X.; Yu, C. Effects of temperature on aggregation kinetics of graphene oxide in aqueous solutions. Colloids Surf. A 2018, 538, 63–72. [Google Scholar] [CrossRef]
  45. Park, J.E.; Kang, Y.Y.; Kim, W.I.; Jeon, T.W.; Shin, S.K.; Jeong, M.J.; Kim, J.G. Emission of polybrominated diphenyl ethers (PBDEs) in use of electric/electronic equipment and recycling of e-waste in Korea. Sci. Total Environ. 2014, 470–471, 1414–1421. [Google Scholar] [CrossRef] [PubMed]
  46. Sjodin, A.; Jones, R.S.; Caudill, S.P.; Wong, L.Y.; Turner, W.E.; Calafat, A.M. Polybrominated diphenyl ethers, polychlorinated biphenyls, and persistent pesticides in serum from the National Health and Nutrition Examination Survey: 2003–2008. Environ. Sci. Technol. 2014, 48, 753–760. [Google Scholar] [CrossRef] [PubMed]
  47. World Bank. GDP (Constant 2010 US$)—Canada. Available online: https://data.worldbank.org/indicator/NY.GDP.MKTP.KD?locations=CA (accessed on 1 May 2021).
  48. Malits, J.; Naidu, M.; Trasande, L. Exposure to Endocrine Disrupting Chemicals in Canada: Population-Based Estimates of Disease Burden and Economic Costs. Toxics 2022, 10, 146. [Google Scholar] [CrossRef] [PubMed]
  49. Richardson, V.M.; Staskal, D.F.; Ross, D.G.; Diliberto, J.J.; DeVito, M.J.; Birnbaum, L.S. Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicol. Appl. Pharmacol. 2008, 226, 244–250. [Google Scholar] [CrossRef]
  50. Meerts, I.A.; van Zanden, J.J.; Luijks, E.A.; van Leeuwen-Bol, I.; Marsh, G.; Jakobsson, E.; Bergman, A.; Brouwer, A. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol. Sci. 2000, 56, 95–104. [Google Scholar] [CrossRef]
  51. Sheikh, I.A.; Beg, M.A. Structural studies on the endocrine disrupting role of polybrominated diphenyl ethers (PBDEs) in thyroid diseases. Environ. Sci. Pollut. Res. 2020, 27, 37866–37876. [Google Scholar] [CrossRef]
  52. Sheikh, I.A.; Beg, M.A. Structural binding perspectives of common plasticizers and a flame retardant, BDE-153, against thyroxine-binding globulin: Potential for endocrine disruption. J. Appl. Toxicol. 2022, 42, 841–851. [Google Scholar] [CrossRef]
  53. Zhou, T.; Taylor, M.M.; DeVito, M.J.; Crofton, K.M. Developmental exposure to brominated diphenyl ethers results in thyroid hormone disruption. Toxicol. Sci. 2002, 66, 105–116. [Google Scholar] [CrossRef]
  54. Hamers, T.; Kamstra, J.H.; Sonneveld, E.; Murk, A.J.; Kester, M.H.; Andersson, P.L.; Legler, J.; Brouwer, A. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol. Sci. 2006, 92, 157–173. [Google Scholar] [CrossRef]
  55. Marchesini, G.R.; Meimaridou, A.; Haasnoot, W.; Meulenberg, E.; Albertus, F.; Mizuguchi, M.; Takeuchi, M.; Irth, H.; Murk, A.J. Biosensor discovery of thyroxine transport disrupting chemicals. Toxicol. Appl. Pharmacol. 2008, 232, 150–160. [Google Scholar] [CrossRef]
  56. Meijer, L.; Brouwer, B.; De Jong, F.H.J.; Bergman, Å.; Sauer, P.J.J. Influence of prenatal exposure to selected organohalogans on infant sexual and neurological development. Organohal. Compd. 2008, 70, 658–661. [Google Scholar]
  57. Luan, M.; Liang, H.; Yang, F.; Yuan, W.; Chen, A.; Liu, X.; Ji, H.; Wen, S.; Miao, M. Prenatal polybrominated diphenyl ethers exposure and anogenital distance in boys from a Shanghai birth cohort. Int. J. Hyg. Environ. Health 2019, 222, 513–523. [Google Scholar] [CrossRef] [PubMed]
  58. Abdelouahab, N.; Ainmelk, Y.; Takser, L. Polybrominated diphenyl ethers and sperm quality. Reprod. Toxicol. 2011, 31, 546–550. [Google Scholar] [CrossRef]
  59. Arowolo, O.; Pilsner, J.R.; Sergeyev, O.; Suvorov, A. Mechanisms of Male Reproductive Toxicity of Polybrominated Diphenyl Ethers. Int. J. Mol. Sci. 2022, 23, 14229. [Google Scholar] [CrossRef] [PubMed]
  60. Zhang, Z.; Zhang, X.; Sun, Z.; Dong, H.; Qiu, L.; Gu, J.; Zhou, J.; Wang, X.; Wang, S.L. Cytochrome P450 3A1 mediates 2,2′,4,4′-tetrabromodiphenyl ether-induced reduction of spermatogenesis in adult rats. PLoS ONE 2013, 8, e66301. [Google Scholar] [CrossRef] [PubMed]
  61. van der Ven, L.T.; van de Kuil, T.; Verhoef, A.; Leonards, P.E.; Slob, W.; Canton, R.F.; Germer, S.; Hamers, T.; Visser, T.J.; Litens, S.; et al. A 28-day oral dose toxicity study enhanced to detect endocrine effects of a purified technical pentabromodiphenyl ether (pentaBDE) mixture in Wistar rats. Toxicology 2008, 245, 109–122. [Google Scholar] [CrossRef]
  62. Patel, N.; Kashanian, J.A. Thyroid Dysfunction and Male Reproductive Physiology. Semin. Reprod. Med. 2016, 34, 356–360. [Google Scholar] [CrossRef]
  63. Li, F.; Xie, Q.; Li, X.; Li, N.; Chi, P.; Chen, J.; Wang, Z.; Hao, C. Hormone activity of hydroxylated polybrominated diphenyl ethers on human thyroid receptor-beta: In vitro and in silico investigations. Environ. Health Perspect. 2010, 118, 602–606. [Google Scholar] [CrossRef]
  64. Schriks, M.; Roessig, J.M.; Murk, A.J.; Furlow, J.D. Thyroid hormone receptor isoform selectivity of thyroid hormone disrupting compounds quantified with an in vitro reporter gene assay. Environ. Toxicol. Pharmacol. 2007, 23, 302–307. [Google Scholar] [CrossRef]
  65. Czerska, M.; Zieliński, M.; Kamińska, J.; Ligocka, D. Effects of polybrominated diphenyl ethers on thyroid hormone, neurodevelopment and fertility in rodents and humans. Int. J. Occup. Med. Environ. Health 2013, 26, 498–510. [Google Scholar] [CrossRef]
  66. Mazdai, A.; Dodder, N.G.; Abernathy, M.P.; Hites, R.A.; Bigsby, R.M. Polybrominated diphenyl ethers in maternal and fetal blood samples. Environ. Health Perspect. 2003, 111, 1249–1252. [Google Scholar] [CrossRef] [PubMed]
  67. Roze, E.; Meijer, L.; Bakker, A.; Van Braeckel, K.N.; Sauer, P.J.; Bos, A.F. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ. Health Perspect. 2009, 117, 1953–1958. [Google Scholar] [CrossRef] [PubMed]
  68. Kim, T.H.; Lee, Y.J.; Lee, E.; Patra, N.; Lee, J.; Kwack, S.J.; Kim, K.B.; Chung, K.K.; Han, S.Y.; Han, J.Y.; et al. Exposure assessment of polybrominated diphenyl ethers (PBDE) in umbilical cord blood of Korean infants. J. Toxicol. Environ. Health A 2009, 72, 1318–1326. [Google Scholar] [CrossRef] [PubMed]
  69. Zhang, J.; Jiang, Y.; Zhou, J.; Wu, B.; Liang, Y.; Peng, Z.; Fang, D.; Liu, B.; Huang, H.; He, C.; et al. Elevated body burdens of PBDEs, dioxins, and PCBs on thyroid hormone homeostasis at an electronic waste recycling site in China. Environ. Sci. Technol. 2010, 44, 3956–3962. [Google Scholar] [CrossRef] [PubMed]
  70. Lin, S.M.; Chen, F.A.; Huang, Y.F.; Hsing, L.L.; Chen, L.L.; Wu, L.S.; Liu, T.S.; Chang-Chien, G.P.; Chen, K.C.; Chao, H.R. Negative associations between PBDE levels and thyroid hormones in cord blood. Int. J. Hyg. Environ. Health 2011, 214, 115–120. [Google Scholar] [CrossRef] [PubMed]
  71. Lignell, S.; Aune, M.; Darnerud, P.O.; Stridsberg, M.; Hanberg, A.; Larsson, S.C.; Glynn, A. Maternal body burdens of PCDD/Fs and PBDEs are associated with maternal serum levels of thyroid hormones in early pregnancy: A crosssectional study. Environ. Health 2016, 15, 55. [Google Scholar] [CrossRef]
  72. Herbstman, J.B.; Mall, J.K. Developmental exposure to polybrominated diphenyl ethers and neurodevelopment. Curr. Environ. Health Rep. 2014, 1, 101–112. [Google Scholar] [CrossRef]
  73. Vuong, A.M.; Webster, G.M.; Romano, M.E.; Braun, J.M.; Zoeller, R.T.; Hoofnagle, A.N.; Sjödin, N.; Yolton, K.; Lanphear, B.P.; Chen, A. Maternal Polybrominated Diphenyl Ether (PBDE) Exposure and Thyroid Hormones in Maternal and Cord Sera: The HOME Study, Cincinnati, USA. Environ. Health Perspect. 2015, 123, 1079–1085. [Google Scholar] [CrossRef] [PubMed]
  74. Hagmar, L.; Bjork, J.; Sjodin, A.; Bergman, A.; Erfurth, E.M. Plasma levels of persistent organohalogens and hormone levels in adult male humans. Arch. Environ. Health 2001, 56, 138–143. [Google Scholar] [CrossRef]
  75. Turyk, M.E.; Persky, V.W.; Imm, P.; Knobeloch, L.; Chatterton, R.; Anderson, H.A. Hormone disruption by PBDEs in adult male sport fish consumers. Environ. Health Perspect. 2008, 116, 1635–1641. [Google Scholar] [CrossRef]
  76. Darnerud, P.O. Brominated flame retardants as possible endocrine disrupters. Int. J. Androl. 2008, 31, 152–160. [Google Scholar] [CrossRef] [PubMed]
  77. Walter, K.M.; Lin, Y.P.; Kass, P.H.; Puschner, B. Association of Polybrominated Diphenyl Ethers (PBDEs) and Polychlorinated Biphenyls (PCBs) with Hyperthyroidism in Domestic Felines, Sentinels for Thyroid Hormone Disruption. BMC Vet. Res. 2017, 13, 120. [Google Scholar] [CrossRef] [PubMed]
  78. Guigueno, M.F.; Fernie, K.J. Birds and flame retardants: A review of the toxic effects on birds of historical and novel flame retardants. Environ. Res. 2017, 154, 398–424. [Google Scholar] [CrossRef] [PubMed]
  79. Szabo, D.T.; Richardson, V.M.; Ross, D.G.; Diliberto, J.J.; Kodavanti, P.R.; Birnbaum, L.S. Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol. Sci. 2009, 107, 27–39. [Google Scholar] [CrossRef] [Green Version]
  80. Lee, E.; Kim, T.H.; Choi, J.S.; Nabanata, P.; Kim, N.Y.; Ahn, M.Y.; Jung, K.K.; Kang, I.H.; Kim, T.S.; Kwack, S.J.; et al. Evaluation of liver and thyroid toxicity in SpragueDawley rats after exposure to polybrominated diphenyl ether BDE209. J. Toxicol. Sci. 2010, 35, 535–545. [Google Scholar] [CrossRef]
  81. Kuriyama, S.N.; Wanner, A.; Fidalgo-Neto, A.A.; Talsness, C.E.; Koerner, W.; Chahoud, I. Developmental exposure to low-dose PBDE-99: Tissue distribution and thyroid hormone levels. Toxicology 2007, 242, 80–90. [Google Scholar] [CrossRef] [PubMed]
  82. Kim, T.H.; Lee, Y.J.; Lee, E.; Kim, M.S.; Kwack, S.J.; Kim, K.B.; Chung, K.K.; Kang, T.S.; Han, S.Y.; Lee, J.; et al. Effects of gestational exposure to decabromodiphenyl ether on reproductive parameters, thyroid hormone levels, and neuronal development in Sprague-Dawley rats offspring. J. Toxicol. Environ. Health A 2009, 72, 1296–1303. [Google Scholar] [CrossRef]
  83. Han, Z.; Li, Y.; Zhang, S.; Song, N.; Xu, H.; Dang, Y.; Liu, C.; Giesy, J.P.; Yu, H. Prenatal transfer of decabromodiphenyl ether (BDE209) results in disruption of the thyroid system and developmental toxicity in zebrafish offspring. Aquat. Toxicol. 2017, 190, 46–52. [Google Scholar] [CrossRef]
  84. Rajender, S.; Monica, M.G.; Walter, L.; Agarwal, A. Thyroid, spermatogenesis, and male infertility. Front. Biosci. 2011, E3, 843–855. [Google Scholar] [CrossRef]
  85. Harley, K.G.; Marks, A.R.; Chevrier, J.; Bradman, A.; Sjödin, A.; Eskenazi, B. PBDE concentrations in women’s serum and fecundability. Environ. Health Perspect. 2010, 118, 699–704. [Google Scholar] [CrossRef]
  86. Akutsu, K.; Takatori, S.; Nozawa, S.; Yoshiike, M.; Nakazaw, H.; Hayakawa, K.; Makino, T.; Iwamoto, T. Polybrominated diphenyl ethers in human serum and sperm quality. Bull. Environ. Contam. Toxicol. 2008, 80, 345–350. [Google Scholar] [CrossRef] [PubMed]
  87. Zhang, P.P.; Wang, S.Q. Updated reproductive toxicology of polybrominated diphenyl ether. Zhonghua Nan Ke Xue 2020, 26, 1140–1144. [Google Scholar] [PubMed]
  88. Kuriyama, S.N.; Talsness, C.E.; Grote, K.; Chahoud, I. Developmental exposure to low-dose PBDE-99: Effects on male fertility and neurobehavior in rat offspring. Environ. Health Perspect. 2005, 113, 149–154. [Google Scholar] [CrossRef]
  89. Tseng, L.H.; Lee, C.W.; Pan, M.H.; Tsai, S.S.; Li, M.H.; Chen, J.R.; Lay, J.J.; Hsu, P.C. Postnatal exposure of male mouse to 2,2′,3,3′,4,4′,5,5′,6,6′-decabrominated diphenyl ether: Decreased epididymal sperm functions without alterations in DNA content and histology in testis. Toxicology 2006, 224, 33–43. [Google Scholar] [CrossRef]
  90. van der Ven, L.T.; van de Kuil, T.; Leonards, P.E.; Slob, W.; Canton, R.F.; Germer, S.; Visser, T.J.; Litens, S.; Hakansson, H.; Schrenk, D.; et al. A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE). Toxicol. Lett. 2008, 179, 6–14. [Google Scholar] [CrossRef]
  91. Khalil, A.; Parker, M.; Brown, S.E.; Cevik, S.E.; Guo, L.W.; Jensen, J.; Olmsted, A.; Portman, D.; Wu, H.; Suvorov, A. Perinatal exposure to 2,2′,4′4′ −Tetrabromodiphenyl ether induces testicular toxicity in adult rats. Toxicology 2017, 389, 21–30. [Google Scholar] [CrossRef] [PubMed]
  92. National Biomonitoring Program. Polybrominated Diphenyl Ethers (PBDEs) and Polybrominated Biphenyls (PBBs) Factsheet. Centers for Disease Control and Prevention. 2017. Available online: https://www.cdc.gov/biomonitoring/PBDEs_FactSheet.html (accessed on 24 January 2023).
  93. Sheikh, I.A. Stereoselectivity and potential endocrine disrupting activity of Bis-(2-ethylhexyl) phthalate (DEHP) against human progesterone receptor: A computational perspective. J. Appl. Toxicol. 2016, 36, 741–747. [Google Scholar] [CrossRef] [PubMed]
  94. Zughaibi, T.A.; Sheikh, I.A.; Beg, M.A. Insights into the Endocrine Disrupting Activity of Emerging Non-Phthalate Alternate Plasticizers against Thyroid Hormone Receptor: A Structural Perspective. Toxics 2022, 10, 263. [Google Scholar] [CrossRef]
Ijms 24 03296 g001 550
Figure 1. The molecular interactions of PBDE flame retardants (a) BDE-28, (b) BDE-100, (c) BDE-153 and (d) BDE-154 with amino acid residues in the TRα ligand binding pocket.
Figure 1. The molecular interactions of PBDE flame retardants (a) BDE-28, (b) BDE-100, (c) BDE-153 and (d) BDE-154 with amino acid residues in the TRα ligand binding pocket.
Ijms 24 03296 g001
Ijms 24 03296 g002 550
Figure 2. The molecular interactions of a TRα amino acid residues lining the ligand binding pocket with its native ligand, triiodothyronine (T3).
Figure 2. The molecular interactions of a TRα amino acid residues lining the ligand binding pocket with its native ligand, triiodothyronine (T3).
Ijms 24 03296 g002
Ijms 24 03296 g003 550
Figure 3. Two-dimensional structure of polybrominated diphenyl ethers (PBDEs) flame retardants: BDE-28, BDE-100, BDE-153, BDE-154, and a TRα native ligand, T3.
Figure 3. Two-dimensional structure of polybrominated diphenyl ethers (PBDEs) flame retardants: BDE-28, BDE-100, BDE-153, BDE-154, and a TRα native ligand, T3.
Ijms 24 03296 g003
Table
Table 1. Structural binding indices of polybrominated diphenyl ethers (PBDEs) flame retardants; BDE-28, BDE-100, BDE-153, BDE-154 and a TRα native ligand, T3.
Table 1. Structural binding indices of polybrominated diphenyl ethers (PBDEs) flame retardants; BDE-28, BDE-100, BDE-153, BDE-154 and a TRα native ligand, T3.
LigandNumber of Interacting TRα ResiduesPercentage of Interacting Residues Common with Native Ligand (%)IFD ScoreDocking Score (Kcal/mol)Glide Score (Kcal/mol)MMGB-SA
(Kcal/mol)
BDE-282281.81−558.04−7.24−7.24−93.19
BDE-1002185.75−558.16−7.03−7.03−114.81
BDE-1531973.68−560.99−8.78−8.78−146.89
BDE-1541894.44−561.93−8.85−8.85−133.29
T323100−564.42−9.44−9.44−133.53
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sheikh, I.A.; Beg, M.A.; Hamoda, T.A.-A.A.-M.; Mandourah, H.M.S.; Memili, E. An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility. Int. J. Mol. Sci. 2023, 24, 3296. https://doi.org/10.3390/ijms24043296

AMA Style

Sheikh IA, Beg MA, Hamoda TA-AA-M, Mandourah HMS, Memili E. An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility. International Journal of Molecular Sciences. 2023; 24(4):3296. https://doi.org/10.3390/ijms24043296

Chicago/Turabian Style

Sheikh, Ishfaq Ahmad, Mohd Amin Beg, Taha Abo-Almagd Abdel-Meguid Hamoda, Hammam Mahmoud Siraj Mandourah, and Erdogan Memili. 2023. "An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility" International Journal of Molecular Sciences 24, no. 4: 3296. https://doi.org/10.3390/ijms24043296

APA Style

Sheikh, I. A., Beg, M. A., Hamoda, T. A. -A. A. -M., Mandourah, H. M. S., & Memili, E. (2023). An Analysis of the Structural Relationship between Thyroid Hormone-Signaling Disruption and Polybrominated Diphenyl Ethers: Potential Implications for Male Infertility. International Journal of Molecular Sciences, 24(4), 3296. https://doi.org/10.3390/ijms24043296

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop